Clinical Research Directory
Browse clinical research sites, groups, and studies.
Do Endotypes Predict Response and Sequelae in OSA Patients
Sponsor: University of California, San Diego
Summary
This study will investigate why some people have Obstructive Sleep Apnea (OSA) and how the underlying cause may relate to OSA manifestations (including sleepiness and high blood pressure) and response to different therapeutic approaches (ie CPAP, eszopiclone, and supplemental oxygen). Understanding why someone has OSA could affect how best to treat that individual, but may also have an impact on what problems the disease might cause.
Key Details
Gender
All
Age Range
21 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2020-08-01
Completion Date
2027-01-01
Last Updated
2024-10-02
Healthy Volunteers
No
Interventions
Eszopiclone
2mg of Eszopiclone just before going to sleep.
Supplemental Oxygen
Constant oxygen flow at 4 Liters per minutes for the duration of time in bed via nasal cannula.
Continuous Positive Airway Pressure (CPAP)
A standard CPAP device will be provided using the settings as prescribed by the treating physician.
Locations (1)
Altman Clinical and Translational Research Institute Building
La Jolla, California, United States